In the future, studies on macromolecular interactions, conformational dynamics, and biochemical functions of RNF213 may reveal the role and mechanism of action of this E3 in MMD and accelerate the development of RNF213‐targeting therapies for MMD. The gene discussed is RNF213; the disease is multiminicore myopathy.